Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: a sub-analysis of the DIVERSITY-CVR study, (Kota Takuma), (Ayako Fuchigami), Fumika Shigiyama, Naoki Kumashiro, Takahisa Hirose, Diabetes, Obesity and Metabolism, 25:2131-2141, 2023年08月
Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue-specific insulin sensitivity in patients with early-stage type 2 diabetes with nonalcoholic fatty liver disease: a prospective randomized study, (Shigenori Hiruma), Fumika Shigiyama, Naoki Kumashiro, Diabetes, Obesity and Metabolism, 25:1576-1588, 2023年06月
Comparison of the effects of pemafibrate and omega-3 fatty acid ethyl on fatty liver index in patients with dyslipidemia treated with statin: a sub-analysis from the PROUD48 study, Yasutaka Takeda, (Masato Furuhashi), Ichiro Sakuma, Shinya Hiramitsu, Mizuho Okada, Shinichiro Ueda, Naoki Kumashiro, Masaru Sakurai, Frontiers in endocrinology, 16:1549687:doi: 10.3389/fendo.2025.1549687. eCollection 2025, 2025年05月